* Encompass Health Corp EHC.N EHC is expected to show a
rise
in quarterly revenue when it reports results on August 1.
* The Birmingham Alabama-based company is expected to
report a
4.4% increase in revenue to $1.344 billion from $1.29 billion a
year ago, according to the mean estimate from 12 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for Encompass Health
Corp is
for earnings of 97 cents per share. For the same quarter last
year, the company reported earnings of $1.17 per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 14 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Encompass
Health
Corp is $79, above its last closing price of $50.62.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2022 0.90 0.92 0.97 Beat 5.7
Dec. 31 2022 1.04 1.05 0.97 Missed -7.5
Sep. 30 2021 1.06 1.06 1.03 Missed -2.7
Jun. 30 2021 0.98 0.97 1.17 Beat 20.2
Mar. 0.83 0.82 1.05 Beat 27.8
31 2021
Dec. 31 2020 0.86 0.85 0.93 Beat 8.8
Sep. 30 2020 0.73 0.74 0.78 Beat 4.9
Jun. 30 2020 0.29 0.39 0.31 Missed -19.6
This summary was machine generated July 30 at 00:30 GMT. All
figures in US dollars unless otherwise stated